http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111344280-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C57-145 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-44 |
filingDate | 2018-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-111344280-B |
titleOfInvention | (E)-N-(3-cyano-7-ethoxy-4-((4-phenoxyphenyl)amino)quinolin-6-yl)-4-(dimethylamino)butan- 2-Enamide maleate and its crystal form |
abstract | This application relates to (E)-N-{4-[3-chloro-4-(2-pyridylmethoxy)aniline]-3-cyano-7-ethoxy-6-quinolinyl}-4 Maleate salt of -(dimethylamino)-2-butenamide, its crystalline form, a process for its preparation, a pharmaceutical composition comprising the same and its use in the control of disorders. |
priorityDate | 2017-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.